Blu Label Unlimited Group (BLU) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
8 Sep, 2026Executive summary
Operating environment was challenging due to high interest rates, inflation, and record unemployment in South Africa, with significant loadshedding impacting both businesses and consumers.
Load shedding affected operations for most of the year, but improved energy availability in the last quarter provided relief and a positive outlook.
Continued investment in digital platforms and financial inclusion, focusing on underserved communities, SMEs, and a people-centric culture with leadership development.
Emphasis on company culture, leadership, and diversity, with new cornerstone values established.
Financial highlights
Revenue for the year ended May 2024 was ZAR 14.6 billion; gross revenue (including PINless top-ups and vouchers) rose 16% to ZAR 89.3 billion from ZAR 76.8 billion.
Gross profit decreased 5% to ZAR 3.3 billion, but gross profit margin improved to 22.57% from 18.41% year-over-year.
Core headline earnings per share declined 34% to ZAR 0.6866, excluding non-recurring and Cell C recapitalisation effects.
EBITDA margin increased to 8.39% from 6.96% year-over-year; EBITDA declined 18% to ZAR 1.205 billion, mainly due to lower performance at CEC.
Cash and cash equivalents at year-end were ZAR 896 million, down from ZAR 1.3 billion, reflecting significant cash outflows.
Outlook and guidance
Focus remains on execution, leveraging data insights, and IT architecture development.
Board to reconsider dividends and/or share buybacks in the next year after meeting all debt obligations by September.
Positive outlook for the remainder of the year due to improved energy availability and operational stability.
Cell C's recapitalization program continues for another 4.5 years, with positive operating cash flow but no free cash flow expected in the near term.
Latest events from Blu Label Unlimited Group
- AGM approved key resolutions, addressed diversity, ESG, and Cell C governance, with most motions passed.BLU
AGM 2024 - Significant declines in earnings expected due to Cell C restructuring and listing impacts.BLU
Trading update - Normalized revenue ZAR 9.4bn, EBITDA ZAR 923m, core headline earnings ZAR 681m, dividend and buyback.BLU
H2 2026 - Earnings per share are expected to rise over 100%, but underlying earnings fell when excluding Cell C effects.BLU
Trading update - Earnings per share are expected to rise by over 20% for the year ended 31 May 2025.BLU
Trading update - Earnings per share to fall over 20%, impacted by Cell C restructuring and related losses.BLU
Trading update - Gross revenue up 8% to R47.4bn, margins improved, but EBITDA fell on higher finance costs.BLU
H1 2025 - Profit and margin growth accelerated, led by digital innovation and Cell C's operational turnaround.BLU
H2 2025 - Cell C restructuring and 11% revenue growth enabled dividend resumption and strong cash flow.BLU
H1 2026